A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorder	Recruiting	Phase 3	2026-10-09		NCT07778836

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Larimar Therapeutics, Inc.	2

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clinilabs	Eatontown	United States	2
Morsani Center for Advanced Health Care, University of South Florida Health	Tampa	United States	2
Northwestern Medical Group, Department of Neurology	Chicago	United States	3
University of Texas Southwestern Medical Center	Dallas	United States	249